Literature DB >> 2001177

Three antibody molecules can bind simultaneously to each monomer of the tetramer of influenza virus neuraminidase and the trimer of influenza virus hemagglutinin.

D C Jackson1, B S Crabb, P Poumbourios, W R Tulip, W G Laver.   

Abstract

Trimeric hemagglutinin and tetrameric neuraminidase molecules isolated from influenza virus bind an average of 9 and 13 molecules respectively of monovalent antibody fragments prepared from IgG isolated from polyclonal sera. In each case this represents an average of approximately three molecules of antibody binding to each protomer. Although there is compelling evidence for the presence of multiple adjacent and overlapping epitopes covering the surface of these two viral antigens, steric hindrance ensures that even under saturating conditions only three molecules of monovalent antibody fragments can be simultaneously accommodated on each monomer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001177     DOI: 10.1007/bf01319230

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  37 in total

1.  Some immunochemical differences between associated and dissociated hemocyanin.

Authors:  A H BARTEL; D H CAMPBELL
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

Review 2.  The neuraminidase of influenza virus.

Authors:  G M Air; W G Laver
Journal:  Proteins       Date:  1989

3.  Antigenic determinants of influenza virus hemagglutinin. VII. The carbohydrate side chains of A/Memphis/102/72 hemagglutinin heavy chain which cross-react with host antigen.

Authors:  C W Ward; L E Brown; J C Downie; D C Jackson
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

Review 4.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin.

Authors:  M Knossow; R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

6.  A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2).

Authors:  D C Jackson; R G Webster
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

7.  The stoichiometry of binding between monoclonal antibody molecules and the hemagglutinin of influenza virus.

Authors:  P Poumbourios; L E Brown; D O White; D C Jackson
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

8.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

9.  Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.

Authors:  G M Air; M C Els; L E Brown; W G Laver; R G Webster
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

10.  Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.

Authors:  R G Webster; L E Brown; W G Laver
Journal:  Virology       Date:  1984-05       Impact factor: 3.616

View more
  5 in total

1.  Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

Authors:  E Varecková; V Mucha; F Ciampor; T Betáková; G Russ
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Neutralizing antibodies to different proteins of African swine fever virus inhibit both virus attachment and internalization.

Authors:  P Gómez-Puertas; F Rodríguez; J M Oviedo; F Ramiro-Ibáñez; F Ruiz-Gonzalvo; C Alonso; J M Escribano
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition.

Authors:  B E Johansson; E D Kilbourne
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

4.  Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.

Authors:  R Glück; R Mischler; S Brantschen; M Just; B Althaus; S J Cryz
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  Model-based inference of neutralizing antibody avidities against influenza virus.

Authors:  Janina Linnik; Mohammedyaseen Syedbasha; Yvonne Hollenstein; Jörg Halter; Adrian Egli; Jörg Stelling
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.